Mesna

美司钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMesna
Drug Alias Name美司那MesnexUromitexanD-7093UCB-3983 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsChemotherapy induced poisoningPoisoningDrug-Related Side Effects and Adverse Reactions +[6] 
Global Approved IndicationsChemotherapy induced poisoningPoisoningDrug-Related Side Effects and Adverse Reactions
Approved Indications in ChinaDrug-Related Side Effects and Adverse Reactions
Original Approved Country/TerritoryUnited States
Original Approved Date1988/12/30
Country/TerritoryCanadaUnited StatesNorway +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesBaxter HlthcareUniversity Of OsloShionogi & Co Ltd +[4] 
Inactive CompaniesLawson Health Research InstituteUlm University
Active IndicationsChemotherapy induced poisoningPoisoningDrug-Related Side Effects and Adverse Reactions +[4] 
Inactive IndicationsKidney Failure, ChronicRenal Insufficiency, Chronic

Other Information

ATC CodeR05CB05V03AF01
Related LinksWikipediaDrugBankKEGG